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Vibrio spp. are associated with infections caused by
contaminated food and water. A type III secretion
system (T3SS2) is a shared feature of all clinical
isolates of V. parahaemolyticus and some
V. cholerae strains. Despite its being responsible for
enterotoxicity, no molecular mechanism has been
determined for the T3SS2-dependent pathogenicity.
Here, we show that although Vibrio spp. are typically
thought of as extracellular pathogens, the T3SS2 of
Vibriomediates host cell invasion, vacuole formation,
and replication of intracellular bacteria. The
catalytically active effector VopC is critical for Vibrio
T3SS2-mediated invasion. There are other marine
bacteria encoding VopC homologs associated with
a T3SS; therefore, we predict that these bacteria are
also likely to use T3SS-mediated invasion as part of
their pathogenesis mechanisms. These findings
suggest a new molecular paradigm for Vibrio patho-
genicity and modify our view of the roles of T3SS
effectors that are translocated during infection.INTRODUCTION
A type III secretion system (T3SS) is used by bacterial pathogens
to inject effector proteins into the cytoplasm of their host cells.
While the T3SS machinery is often conserved among Gram-
negative pathogens, the effectors from each system differ widely
in their mechanism of action. These effectors are typically potent
proteins thatmimic or capture an endogenous eukaryotic activity
to disrupt the cellular response to infection (Broberg and Orth,
2010; Ham et al., 2011). Comparative genome analysis has
demonstrated that a common Vibrio progenitor gave rise to
V. parahaemolyticus, V. cholerae, and other Vibrio species
(Okada et al., 2009). The acquisition of a T3SS similar to that
found in Yersinia species (causal agent of the Plague and gastro-
enteritous), herein referred to as T3SS1, is one of the distinguish-
ing features between V. parahaemolyticus and V. cholerae
(Okada et al., 2010a).The more recent acquisitions by V. parahaemolyticus of
a second type III secretion system (T3SS2), thermostable direct
hemolysins (TdhA/S) and TDH related hemolysin (TRH), have
given rise to a diverse set of pathogenic strains, enabling the
bacteria to adapt a host-associated lifestyle (Makino et al.,
2003; Nishibuchi and Kaper, 1995). T3SS2 is located on a patho-
genicity island that is hypothesized to be encoded on a mobile
genetic element and is a shared feature of all characterized clin-
ical isolates of V. parahaemolyticus and some V. cholerae strains
(Okada et al., 2010b). Despite its discovery more than sixty years
ago and suggestions that some V. parahaemolyticus strains are
invasive, no molecular mechanism has been determined for the
pathogenicity linked to clinical presentation of gastroenteritis
(Akeda et al., 1997; Broberg et al., 2011; Makino et al., 2003).
Herein, we have discovered that the enterotoxic T3SS2mediates
invasion of V. parahaemolyticus into nonphagocytic cells using
an effector, VopC (Park et al., 2004a). This mechanism also
appears to be shared by some epidemic V. cholerae non-O1
strains that do not contain cholera toxin. This VopC-containing
T3SS is found in a number of marine bacteria, suggesting a
previously uncharacterized pathogenesis mechanism for these
bacterial pathogens.
RESULTS
T3SS2 of V. parahaemolyticus Mediates Bacterial
Invasion into Nonphagocytic Host Cells
On the basis of G-C content, the T3SS1 of V. parahaemolyticus
was ancestrally acquired, while the clinically associated T3SS2
was obtained through a relatively recent lateral gene transfer of
a pathogenicity island (Makino et al., 2003). Although the evolu-
tionary history of V. parahaemolyticus subsequently diverged
from that of V. cholerae, in which some strains acquired either
a T3SS2 or a phage-encoded cholera toxin, respectively, the
two species contain remarkable similar T3SS2s and the effectors
associated with this secretion system are well conserved (Okada
et al., 2010b). Among known T3SS2 effectors, there is VopC
(VPA1321 in V. parahaemolyticus RIMD2210633), which shows
sequence similarity to the catalytic domain of cytotoxic necro-
tizing factor (CNF) toxins, including those secreted by Yersinia
spp., Bordetella spp., and Escherichia coli (Table S1).
V. parahaemolyticus appears to have hijacked the catalyticCell Reports 1, 1–8, May 31, 2012 ª2012 The Authors 1
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rep.2012.04.004domain from the toxins, since VopC encodes for a T3SS2 secre-
tion signal linked to that enzymatic domain. By contrast, the
toxins must encode distinct domains for them to be secreted
by bacteria, to be taken up by the host cells, and to modify
host cell targets. These toxins induce changes in cell shape
and facilitate invasion of the pathogens into the host cell (Akto-
ries and Barbieri, 2005). Therefore, it is logical to ask whether
Vibrio T3SS2 uses VopC to mediate bacterial invasion into
a host cell.
Our studies into the role of the V. parahaemolyticus T3SS2 and
initial examination of Vibrio invasion involve the CAB2 strain,
derived from the pathogenic RIMD strain. CAB2 contains an
active T3SS2 but does not express the hemolysins and T3SS1,
which allows for T3SS2 activity to be studied independently of
other virulence factors. As a control we used the CAB4 strain,
which does not contain active hemolysins, T3SS1 or T3SS2
(Table S2). Initial infection and cytotoxicity assays demonstrated
that CAB2 induced with bile salt was able to cause changes in
cell shape, followed by cell lysis approximately 4–5 hr after infec-
tion (Gotoh et al., 2010) (Figures 1A–1D). Surprisingly, our obser-
vations also suggested that the T3SS2-only CAB2 was invading
host cells. When invasion of nonphagocytic HeLa cells was
analyzed over time, the amount of intracellular CAB2 increased
in the first few hours of infection and then precipitously dropped
at approximately 4–5 hr, coincident with the timing of cell lysis
(Figure 1E). The numbers of intracellular bacteria over time after
initial infection were also quantitated by incubating the infected
cells in medium containing gentamicin to kill extracellular
bacteria and eliminate the possibility of reinfection. An increase
in the number of surviving (intracellular) bacteria, followed by
a dramatic decrease coincident with cell lysis at the end of the
time course, suggests that Vibrio was able to replicate inside
host cells (Figure 1F). The invasion efficiency of CAB2 was
comparable to that of the intracellular pathogen Shigella flexneri
(Figure 1G), and we observed similar results with differentiated
epithelial colorectal CaCo2 cells (Figure S1). These studies
support the hypothesis that V. parahaemolyticus uses a
T3SS2-mediated mechanism for invasion, intracellular replica-
tion, and lysis of infected cells and is consistent with an early,
isolated observation for a few invasive pathogenicV. parahaemo-
lyticus strains (Akeda et al., 1997).
To further characterize host cell invasion, we analyzed HeLa
cells infected with the same V. parahaemolyticus strains by
transmission electron microscopy (TEM). HeLa cells infected
with CAB2, but not CAB4, contained intracellular bacteria
(Figures 1H and 1I).
The T3SS2 Effector VopC Promotes Vibrio Invasion
by Activating Rac and CDC42
Next, we investigated the role of VopC in T3SS2-mediated inva-
sion. The catalytic domain shared by VopC and the CNF toxins is
predicted to have deamidase/transglutaminase activity that has
been associated with modification of Rho family GTPases,
including Rac, Rho, and/or CDC42 (Flatau et al., 1997). The
conserved catalytic residues in VopC are cysteine 220 and
histidine 235 (866 and 881 in CNF1, respectively) (Figure 2A).
Modified by toxins CNF or DNT (Bordetella dermonecrotizing
toxin) through deamidation or transglutamination, respectively,2 Cell Reports 1, 1–8, May 31, 2012 ª2012 The Authorsa RhoGTPase becomes constitutively active, triggering changes
in the actin cytoskeleton of the infected cell (Masuda et al., 2000;
Schmidt et al., 1997). These changes in cell shape facilitate inva-
sion of the pathogens into the host cell (Doye et al., 2002).
Therefore, we tested whether Vibrio invasion was dependent
on the presence of VopC. CAB2 and CAB2DvopC+VopC, but
not CAB2DvopC, were able to invade HeLa cells (Figures 2B–
2D), suggesting a critical role for VopC in invasion. While VopC
is necessary for invasion, the cytotoxicity of T3SS2 is indepen-
dent of VopC and is most likely due to the delivery of other effec-
tors (Figures S2A and S2B). To assess whether the enzymatic
activity of VopC was critical, we analyzed invasion mediated
by the VopC deletion strain complemented with the putative
catalytically inactive VopC C220S. In contrast to the CAB2D
vopC+VopC strain, the CAB2DvopC+VopC C220S strain was
unable to mediate invasion (Figure 2B), while VopC C220S was
expressed and secreted at a level similar to that of wild-type
VopC (Figure S2C). Cytoskeletal inhibitors were reported to be
able to block invasive V. parahaemolyticus (Akeda et al., 1997).
In the presence of inhibitors nocodazole or cytochalasin D,
CAB2 was indeed no longer invasive, supporting the hypothesis
that VopC induces changes in cytoskeleton shape to facilitate
invasion (Figure 2B). To further investigate the invasion process,
we analyzed HeLa cells infected with various strains by TEM.
HeLa cells infected with CAB2DvopC+VopC, but not CAB2D
vopC, contained intracellular bacteria (Figures 2C and 2D). The
number of intracellular bacteria varied, and in some cases, intra-
cellular bacteria appeared to be replicating (Figure 2C).
Next, we assessedwhether VopC uses amechanism similar to
CNF toxins by analyzing the active state of host GTPases. Over
the course of infection with CAB2, but not with CAB2DvopC,
CDC42 was activated, as demonstrated by its interaction with
its downstream target, the binding domain of p21-activated
kinase 3 (PAK PBD) (Figure 3A). Infections with a deletion strain
reconstituted with wild-type VopC (CAB2DvopC+VopC), but not
with the deletion strain reconstituted with a putative catalytically
inactive VopC (CAB2DvopC+VopC C220S), also caused CDC42
activation without affecting the total level of this GTPase (Fig-
ure 3A). These studies implicate the catalytic activity of VopC
in the activation of Rho GTPases during infection.
To further test the activity of VopC, we transfected HeLa
cells with VopCD67, an N-terminal truncation that retains the
catalytic domain but removes the putative signal sequence to
aid expression. Transfection of HeLa cells with VopCD67, but
not GFP or VopCD67 C220S, induced the formation of both
actin ruffles and filopodia (Figures 3B–3G). These changes in
cell morphology appeared to be due to the enzymatic activity
of VopC, because transfection of the predicted catalytically inac-
tive VopCD67 C220S did not induce changes in the actin cyto-
skeleton when the proteins were expressed at a similar level in
HeLa cells (Figure S3A).
Further biochemical analysis of the transfected cells revealed
that the expression of VopCD67, but not VopCD67 C220S,
caused the activation of both Rac and CDC42, but not RhoA,
as measured by the ability of the activated GTPases to interact
with their downstream targets, PAK PBD or the binding domain
of Rhotekin, respectively (Figure 3H). The specificity of VopC
for Rac and CDC42 but not RhoA is distinct from the activities
Figure 1. V. parahaemolyticus Invasion into HeLa Cells
(A–C) HeLa cells uninfected and infected with CAB2 or CAB4 after 5 hr, respectively. Nuclei were stained with Hoechst (blue), and the actin cytoskeleton was
stained with rhodamine-phalloidin (red).
(D) HeLa cells infected with CAB2 (open circles) or CAB4 (closed circles) and LDH release evaluated to measure cytotoxicity. Error bars represent mean ± SD
(n = 3).
(E) HeLa cells infected with CAB2. Invasion percentages were determined at indicated time points. Results are calculated from the numbers of intracellular
bacteria collected per the numbers of total bacteria incubated in the same condition at indicated time points. Error bars represent mean ± SD (n = 3).
(F) HeLa cells were infected with CAB2 for 2 hr and incubated in medium containing gentamicin. The intracellular bacteria were determined at the indicated time
points. Error bars represent mean ± SD (n = 3).
(G) HeLa cells were infected with CAB2, CAB4, or Shigella for 2 hr, and invasion percentages were determined. Results are calculated from the numbers of
intracellular bacteria collected per the number of total bacteria. Error bars represent mean ± SD (n = 3).
(H and I) HeLa cells infected with CAB2 and CAB4, respectively. Scale bar represents 1 mm.
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rep.2012.04.004observed with the secreted CNF toxins, where CNF1 and DNT
activate Rac, CDC42, andRhoA by deamidation and/or transglu-
tamination (Horiguchi, 2001).
The T3SS2 Effector VopC Activates Rac by Deamidation
of Glutamine 61
To test the biochemical activities of VopC, we first performed
a transglutamination assay using the fluorescent amine-donor
dansylcadaverine and Rho GTPases as substrates. MBP-VopCD67, but not MBP-VopCD67 C220S, was able to transglu-
taminate Rac and CDC42, but not RhoA with dansylcadaverine,
which is consistent with the selective activation of these
GTPases observed during transfection (Figures 3H and 3I, Fig-
ure S3B). CNF1 and DNT toxins modify Q61 in the switch 2
region of Rac and CDC42, resulting in constitutive activation of
these small G proteins (Aktories and Barbieri, 2005). We
observed that VopC was unable to transglutaminate a Rac
Q61L mutant, supporting the hypothesis that VopC also targetsCell Reports 1, 1–8, May 31, 2012 ª2012 The Authors 3
Figure 2. VopC Promotes Vibrio Invasion by Activating Rac and CDC42
(A) Multiple sequence alignment of VopC effectors and CNF and DNT toxins. Sequences are labeled according to species and residue numbers left of the
alignment. Conserved residues are shown in yellow (similar) and red (identical). Conserved catalytic residues are marked by an asterisk. Secondary structure
elements indicated are based on the structure of the catalytic domain of E. coli CNF1 (PDB 1HQ0) (SS: red cylinder a-helix; blue arrow: b strand). Alignments are
shown for VopC (VPA1321), VopC (A55_B0294), CNF1 (UTI89_C4921), CNFY (YPK_2615), and DNT (BB3978).
(B) HeLa cells infected with CAB2, CAB4, CAB2DvopC, CAB2DvopC + VopC, CAB2DvopC + VopC C220S, or CAB2 in the presence of cytochalasin D or no-
codazole. Error bars represent mean ± SD (n = 3). Asterisks indicate statistically significant differences between intracellular CAB2 and CAB2DvopC (p = 0.0003,
n = 3) and between intracellular CAB2DvopC + VopC and CAB2DvopC + VopC C220S (p = 0.0004, n = 3), with the use of a two-tailed t test.
(C and D) HeLa cells infected with CAB2DvopC + VopC or CAB2DvopC. Arrow indicates replicating bacterium inside a HeLa cell. Scale bar represents 1mm.
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rep.2012.04.004this residue specifically (Figure 3I). We further observed that
MBP-VopCD67, but not MBP-VopCD67 C220S, could also act
as a deamidase. Ammonia release resulting from a deamidation
reaction was detected when VopC was incubated with Rac, but
not RacQ61L, further suggesting that Q61 is the target residue of
VopC activity (Figure 3J). To confirm the activity and residue
specificity that VopC exerts on Rho family GTPases, we ex-
pressed GST-Rac in the presence or absence of MBP-VopCD67
and determined the total mass of purified GST-Rac by mass
spectrometry (MS). No significant difference was observed
between Rac and Rac coexpressed with VopC. Since a tranglu-
taminase reaction would add substantial mass, this result
suggests that the reaction does not occur when these proteins
are coexpressed (Figure S4). We analyzed chymotryptic digests
of the two Rac samples using liquid chromatography followed by
MS to determine whether Q61 had been modified. MS analysis
demonstrated that only the deamidated form of Q61 was
detected when Rac was coexpressed with VopC, while no dea-
midated form of Q61 was detected in the control sample,4 Cell Reports 1, 1–8, May 31, 2012 ª2012 The Authorsdemonstrating that VopC activated Rac by deamidation of Q61
(Figure 3K, Figure S4, Table S3).
VopC-Mediated Bacterial Invasion Is Conserved in
V.cholerae Strains
Some pathogenic V. cholerae non-O1 strains contain a T3SS2-
like gene cluster encoding a similar repertoire of effectors,
including VopC. Interestingly, two of these clinical isolates,
V. cholerae 1587 and 623-39, in contrast to the well-studied
V. cholerae serotypes O1 and O139, do not contain a cholera
toxin, but are correlated with sporadic cholera epidemics,
pathology in animal models, and limited, albeit unexplained
cell invasion (Dalsgaard et al., 1995). Similar to
V. parahaemolyticus, we observed cytotoxicity induced by
V. cholerae 1587. Using time-course invasion experiments and
LDH release assays, we obtained results that suggested that
V. cholerae 1587 could replicate inside HeLa cells (Figures 4A–
4C). We observed that V. cholerae 1587, but not the
V. cholerae O1 El Tor strain, which contains cholera toxin but
Please cite this article in press as: Zhang et al., Type III Effector VopC Mediates Invasion for Vibrio Species, Cell Reports (2012), doi:10.1016/j.cel-
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a manner similar to that observed with V. parahaemolyticus
(Figure 4D). Furthermore, V. cholerae 1587DvopC was no longer
able to invade HeLa cells, and actin accumulation inhibitor
cytochalasin D was able to block V. cholerae 1587 invasion,
suggesting VopC has a similar role for invasion in V. cholerae
as in V. parahaemolyticus. Thus, these V. cholerae non-O1
strains contain an active T3SS that mediates their invasion into
host cells.DISCUSSION
We have discovered that T3SS2 enables V. parahaemolyticus to
act as an invasive pathogen. This T3SS2-mediated invasion is
dependent on the presence of the effector VopC that has a dea-
midase/transglutaminase activity. Upon translocation into the
host cell, VopC activates small GTPases Rac and CDC42 to
induce changes in the actin cytoskeleton and facilitate the entry
of V. parahaemolyticus into nonphagocytic host cells. It is
possible that other known and unknown effectors secreted by
T3SS2 may facilitate pathogen survival and replication inside
the host cell, as well as cell lysis when a critical intracellular
bacterial burden has been reached. Other known T3SS2 effec-
tors include VopP/A, a Ser/Thr acetyltransferase; VopL/F, an
actin nucleator; and VopV, an actin bundling protein (Hiyoshi
et al., 2011; Liverman et al., 2007; Okada et al., 2010b; Trosky
et al., 2007). We propose that these effectors are likely to be
involved in the intracellular survival, replication, and spreading
of these Vibrio species within the infected host. Although a direct
connection between T3SS2-mediated invasion and T3SS2-
mediated enterotoxicity has not been established, future studies
will no doubt elucidate the molecular mechanisms of other yet-
to-be-characterized T3SS2 effectors and how T3SS2 might
contribute to possible intracellular pathogenesis.
Herein, we also observed that another pathogenic bacterium,
a V. cholerae non-O1, non-O139 strain, contains a T3SS2 with
a similar repertoire of effectors, including VopC. This strain of
V. cholerae does not encode a cholera toxin but is involved in
limited epidemic outbreaks (Dalsgaard et al., 1995). We propose
that this pathogenicity for V. cholerae may be mediated by the
recently acquired T3SS2 that allows for invasion. Our observa-
tions suggest that the V. cholerae T3SS2 functions indepen-
dently of cholera toxin and could be sufficient for pathogenicity
of V. cholerae during infection of its animal host.
Finally, the implications for invasive bacteriamost likely extend
beyond Vibrio, as there are other species of bacteria frommarine
environments that have acquired a T3SS encoding a VopC
homolog (Table S1). These observations present another molec-
ular paradigm for Vibrio pathogenicity, and future studies on
invasion, survival, and spreading of the bacteria within the host
will undoubtedly result in better understanding of signaling
mechanisms used by both the host and the pathogen.EXPERIMENTAL PROCEDURES
Bacterial Strains
V. parahaemolyticus CAB strains were derived from POR1 (RIMD 2210633
DtdhAS), generously provided by Drs. Tetsuya Iida and Takeshi Honda (Parket al., 2004b). They were created by deleting the transcription factors ExsA
and/or VtrA that regulate the two T3SSs (Kodama et al., 2010; Kodama
et al., 2007; Zhou et al., 2008). To induce T3SS2, media was supplemented
with 0.05% bile salt and bacteria were grown at 37C for 2 hr (Gotoh et al.,
2010). V. cholerae strain 1587 was generously provided by Dr. John Mekala-
nos, and it was grown in LB at 37C.
LDH Assays
LDH release at each indicated time point was measured in triplicate with the
use of a Cytotoxicity Detection Kit (Takara) according to the manufacturer’s
instructions. Results are presented as cytotoxicity as calculated from percent
of total lysis.
Invasion Assays
HeLa cells were infected at a multiplicity of infection (MOI) of 10 for the
indicated time points. At each time point, 100 mg/ml gentamicin was added
to kill extracellular bacteria. Cells were lysed with 0.5% Triton X-100 and the
intracellular bacteria were assessed. For the gentamicin incubation experi-
ments, cells were infected for 2 hr, washed with DMEM, and incubated in
DMEM containing 100 mg/ml gentamicin. At each time point, cells were
washed and lysed and the intracellular bacteria were assessed.
Electron Microscopy
HeLa cells were infected for 2 hr and fixed in 2.5% glutaraldehyde in 0.1M
sodium cacodylate, followed by 1%osmium tetroxide in 0.1M sodium cacody-
late. Cells were embedded in epoxy resin (Electron Microscopy Sciences) and
polymerized at 60C. Ultrathin sections were cut at 80 nm and stained with
uranyl acetate and lead citrate. Sections were examined at 120 KV with a Tec-
nai G2 Spirit transmission electron microscope (FEI Company), and images
were recorded on a Gatan USC1000 2k CCD camera (Gatan).
VopC Deletion Strain
The nucleotide sequences 1 kb upstream and 1 kb downstream of VopC were
cloned into pDM4, a CmROriR6K suicide plasmid (kindly provided by Dr. Doug
Call). The resulting plasmid was conjugated into CAB2 and transconjugants
were selected on media containing 25 mg/ml chloramphenicol. Bacteria were
counterselected by growing on media containing 15% sucrose.
Reconstitution of CAB2DvopC
The DvopC deletion strain was reconstituted with the use of pBAD (Invitrogen)
containing vopC FLAG or vopC C220S FLAG preceded by 1 kb of its upstream
sequence and a kanamycin resistance gene.
Secretion Assay
pBAD vopC-FLAG or pBAD vopC C220S-FLAG were mated into different
strains. Bacteria were induced with 0.05% bile salt at 37C (Gotoh et al.,
2010). Three hours after induction, the culture was centrifuged to separate
supernatants and pellets. The supernatant was filtered and ice-cold trichloroa-
cetate was added to a final concentration of 10%. Samples were kept on ice
overnight and then centrifuged. The precipitates and pellets were analyzed
by Western blotting with the use of a mouse anti-FLAG antibody (Sigma).
Tissue Culture and Transfection
HeLa cells were cultured in DMEM (Invitrogen) supplemented with 10%
heat-inactivated fetal bovine serum (Sigma) at 37C with 5% CO2. Cells
were transfected with the Fugene HD (Roche) transfection agent according
to the manufacturer’s protocol.
Confocal Microscopy
HeLa cells were fixed in 3.2% paraformaldehyde after treatment. Nuclei were
stained with Hoechst (Sigma), and the actin cytoskeleton was stained with
rhodamine-phalloidin (Molecular Probes). Cells were viewed on a Zeiss LSM
510 scanning confocal microscope, and images were converted with ImageJ
and Adobe Photoshop.Cell Reports 1, 1–8, May 31, 2012 ª2012 The Authors 5
Figure 3. VopC Activates Rac and CDC42 by Deamidation of Glutamine 61
(A) HeLa cells infected with CAB2, CAB2DvopC, CAB2DvopC + VopC, or CAB2DvopC + VopC C220S and tested for active GTP-bound CDC42 with the use of
GST-PAK PBD pull-down assays. For loading control, total cell lysates were immunoblotted with anti-aldolase.
(B–G) HeLa cells transfected with pSFFV-eGFP, pSFFV-GFP-VopCD67, or pSFFV-GFP-VopCD67 C220S. Cells were visualized by confocal microscopy with the
use of GFP (green) to identify transfected cells. Nuclei were stainedwith Hoechst (blue), and actin cytoskeletonwas stainedwith rhodamine-phalloidin (red). Scale
bar represents 10mm.
(H) Transfected HeLa cells tested for active GTP-bound GTPases with the use of GST-PAK PBD (for Rac and CDC42) or GST-Rhotekin (for RhoA) pull-down
assays. For loading control, total cell lysates were immunoblotted with anti-aldolase.
(I) MBP-VopCD67 orMBP-VopCD67 C220S incubated with GST-Rac, GST-CDC42, GST-RhoA, or GST-Rac Q61L in the presence of dansylcadaverine, followed
by UV analysis.
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Figure 4. V. choleraeNon-O1 Strain Invades
HeLa Cells
(A) HeLa cells infected with V. cholerae 1587
(closed circles). LDH release was evaluated as
a measure of cytotoxicity. Error bars represent
mean ± SD (n = 3).
(B) HeLa cells infected with V. cholerae 1587.
Intracellular bacteria were assessed at indicated
time points. Error bars represent mean ± SD
(n = 3).
(C) HeLa cells infected with V. cholerae 1587 for
2 hr and incubated in medium containing genta-
micin. The intracellular bacteria were determined
at the indicated time points. Error bars represent
mean ± SD (n = 3).
(D) HeLa cells infected with CAB2, V. cholerae O1
El Tor, 1587, 1587DvopC, or 1587 in the presence
of cytochalasin D. After 2 hr of infection, intracel-
lular bacteria were assessed. Error bars represent
mean ± SD (n = 3). Asterisks indicate statistically
significant differences between CAB2 and
V. cholerae El Tor invasion, V. cholerae 1587 and
1587DvopC invasion, and V. cholerae 1587 inva-
sion in the absence and presence of cytochalasin
D (*p < 0.0001, n = 3; two-tailed t test).
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HeLa cells were infected at anMOI of 10. At each time point, cells werewashed
and lysates were collected by scraping into Mg2+ lysis buffer (20 mM Tris HCl
[pH 7.5], 10 mM MgCl2, 150 mM NaCl, 1% Triton X-100). Cellular debris was
spun down at 12,0003 g for 20 min, and 500 mg of cleared lysates was added
to 30 mg of GST-PAK PBD on glutathione agarose beads and incubated for 1 hr
at 4C. Samples were separated by SDS-PAGE and immunoblotted with
anti-CDC42 (Cell Signaling). As a loading control, total cell lysates were
immunoblotted with anti-aldolase (Santa Cruz Biotechnology). Transfected
HeLa cells were collected and treated in a similar fashion as described above.
Activated RhoA was pulled down with the use of a RhoA activation kit (Cyto-
skeleton) according to the manufacturer’s instructions.
Recombinant Proteins
pGex-KG-PAK-PBD (provided by Dr. Neal Alto), pGex-KG-RhoA, pGex-
KG-Rac, pGex-KG-Rac Q61L, pGex-KG-CDC42 (provided by Dr. Paul
Sternweis), pET28a-MBP-VopCD67, and pET28a-MBP-VopCD67 C220S
were transformed into BL21 (DE3) (Novagen). His-tagged proteins (MBP-
VopCD67 andMBP-VopCD67C220S) were purified with the use of Ni2+ affinity
purification (QIAGEN). GST-tagged proteins (GST-PAK-PBD, GST-RhoA,
GST-Rac, GST-Rac Q61L, and GST-CDC42) were purified with the use of
glutathione agarose beads (Sigma).
Transglutaminase Assay
A total of 3 mg/ml of GST-RhoA, GST-Rac, GST-Rac Q61L, or GST-CDC42
was incubated with a 1:20 molar ratio of MBP-VopCD67 or MBP-VopCD67
C220S and 5 mM dansylcadaverine (Sigma) at 37C for 2 hr. Samples were
boiled and separated on 12% SDS-PAGE. Gels were examined with UV expo-
sure through the use of an AlphaImager 2200 (Alpha Innotech Corporation),
and images were recorded. Then, gels were stained with Coomassie Brilliant
Blue (Biorad) for protein band observation.(J) MBP-VopCD67 or MBP-VopCD67 C220S incubated with GST-Rac or GST-Rac
were shown between the ammonia release fromGST-Rac incubated with VopC an
represent mean ± SD (n = 3).
(K) Alignment of the switch 2 region from Rac and VopC-modified Rac. The chanDeamidation Assay
A total of 120 mM of GST-Rac or GST-Rac Q61L was incubated with a 1:20
molar ratio of MBP-VopCD67 or MBP-VopCD67 C220S at 37C for 2 hr. The
released NH+4 from glutamine deamidation was measured with the use of an
ammonia assay kit (Sigma) according to the manufacturer’s instructions.
MS
pGex-KG-Rac alone or pGex-KG-Rac and pET28a-MBP-VopCD67 together
were transformed into BL21 (DE3) (Novagen) for protein expression. GST-
Rac was purified with the use of glutathione agarose beads (Sigma). Proxeon
nano-tips (Denmark) were used to inject the samples into a QStar XL Q-TOF
mass spectrometer (Applied Biosystems). Spectra were acquired with
a mass range of m/z 500–2,000. The molecular weights of proteins were
calculated with the Bayesian Protein Reconstruct tool of the Analyst QS1.1
software.
Tandem MS
Ten micrograms of each sample were fractionated by SDS-PAGE, and
bands containing GST-Rac were cut out, treated with DTT and iodoaceta-
mide, and digested with chymotrypsin. Samples from the digests were
analyzed by nano-LC/MS/MS through the use of a system in which a Dionex
LC-Packings HPLC (Sunnyvale, CA) was coupled with an LTQ Orbitrap Velos
(Thermo Scientific).
VopC Deletion in V. cholerae 1587
The V. cholerae 1587DvopC strain was generated essentially as described
previously (Merriam et al., 1997; Walker and Miller, 2004). In brief, regions
1 kb upstream and downstream of VopC were cloned into pSR47S, a KanR
OriR6K suicide plasmid (kindly provided by Dr. Virginia Miller). pSR47s was
then conjugated into V. cholerae 1587 and transconjugants were selected
by replating twice on Vibrio-selective medium (VSM) containing 60 mg/mlQ61L and analyzed for release of ammonia. Statistically significant differences
dGST-Rac alone (p = 0.0036, n = 3) with the use of a two-tailed t test. Error bars
ged residue is highlighted in red.
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